Literature DB >> 4121031

Applications of a synthetic neuraminidase substrate.

P Palese, D Bucher, E D Kilbourne.   

Abstract

A rapid and precise assay for neuraminidase using 2-(3'-methoxyphenyl)-N-acetyl-alpha-neuraminic acid (MPN) is described. It is proposed that this substrate be used for the standardization of activity of neuraminidases from viral, bacterial, and mammalian sources. MPN is also used as a chromogenic substrate to localize influenza and parainfluenza virus foci in tissue culture. This technique permits the recovery of infective virus from these stained "plaques." It has also been demonstrated that immunoprecipitin lines containing neuraminidase complexes with antibody in the Ouchterlony test can be observed by a similar staining procedure. No enzyme inhibition occurs in the presence of anti-neuraminidase antibodies or concanavalin A when MPN is used as a substrate in contrast to the results with high-molecular-weight substrates such as fetuin.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4121031      PMCID: PMC380770          DOI: 10.1128/am.25.2.195-201.1973

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  11 in total

1.  A chromogenic substrate for the investigation of neuraminidases.

Authors:  H Tuppy; P Palese
Journal:  FEBS Lett       Date:  1969-04       Impact factor: 4.124

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Isolation and preliminary characterization of temperature-sensitive mutants of influenza virus.

Authors:  A Sugiura; K Tobita; E D Kilbourne
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

4.  A 2 (N2) neuraminidase of the X-7 influenza virus recombinant: determination of molecular size and subunit composition of the active unit.

Authors:  D J Bucher; E D Kilbourne
Journal:  J Virol       Date:  1972-07       Impact factor: 5.103

5.  Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine.

Authors:  E D Kilbourne; J L Schulman; G C Schild; G Schloer; J Swanson; D Bucher
Journal:  J Infect Dis       Date:  1971-11       Impact factor: 5.226

6.  Recombination of influenza A viruses of human and animal origin.

Authors:  E D Kolbourne
Journal:  Science       Date:  1968-04-05       Impact factor: 47.728

7.  Quantitative determination of neuraminidase-active foci in cell monolayer cultures infected with influenza or newcastle disease virus.

Authors:  P Palese; G Bodo; H Tuppy
Journal:  J Virol       Date:  1970-10       Impact factor: 5.103

8.  A method for the determination of neuraminidase activity in the presence of added neuraminic acids or potential inhibitors.

Authors:  L Holmquist
Journal:  Acta Chem Scand       Date:  1969

9.  Identification in a recombinant influenza virus of structural proteins derived from both parents.

Authors:  W G Laver; E D Kilbourne
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

10.  Coupled-enzyme system for measuring viral neuraminidase activity.

Authors:  D W Ziegler; H D Hutchinson
Journal:  Appl Microbiol       Date:  1972-06
View more
  8 in total

1.  The role of hemagglutinin in the inhibition of neuraminidase activity of influenza virus by concanavalin A. Brief Report.

Authors:  E Zalan; C Wilson; R Freitag
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

2.  Changes in the neuraminidase of neurovirulent influenza virus strains.

Authors:  A C Ward
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

3.  Effect of Ca++ on the stability of influenza virus neuraminidase.

Authors:  N J Baker; S S Gandhi
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

4.  Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells.

Authors:  L de Repentigny; F Aumont; K Bernard; P Belhumeur
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Neuraminidase inhibition by chemically sulphated glycopeptides.

Authors:  N Mian; C E Anderson; P W Kent
Journal:  Biochem J       Date:  1979-08-01       Impact factor: 3.857

6.  Detection of sialidase (neuraminidase) activity in Actinomyces species by using 2'-(4-methylumbelliferyl)alpha-D-N-acetylneuraminic acid in a filter paper spot test.

Authors:  B J Moncla; P Braham
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

7.  Biochemical characterization of extracellular proteases from Vibrio cholerae.

Authors:  D B Young; D A Broadbent
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

8.  Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.

Authors:  Maryna C Eichelberger; Arash Hassantoufighi; Meng Wu; Min Li
Journal:  Virol J       Date:  2008-09-26       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.